Can-Fite BioPharma Ltd . (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncology, inflammatory, and liver diseases, today announced it has been invited to present at the Emerging Growth Conference on Thursday, July 13, 2023 at 11:25 AM ET. This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with Can-Fite’s CEO, Motti Farbstein, in real...